The patient co-payment and opportunity costs of accessing healthcare for Indigenous Australians with cancer: A whole of population data linkage study.
Australia
Cost of Illness
Female
Health Expenditures
/ statistics & numerical data
Health Services Accessibility
/ economics
Hospitalization
/ economics
Humans
Information Storage and Retrieval
Male
Middle Aged
Native Hawaiian or Other Pacific Islander
/ statistics & numerical data
Neoplasms
/ economics
Queensland
/ epidemiology
cancer
expenses
financial toxicity
indigenous
out-of-pocket costs
Journal
Asia-Pacific journal of clinical oncology
ISSN: 1743-7563
Titre abrégé: Asia Pac J Clin Oncol
Pays: Australia
ID NLM: 101241430
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
25
11
2018
accepted:
27
05
2019
pubmed:
18
7
2019
medline:
16
1
2020
entrez:
18
7
2019
Statut:
ppublish
Résumé
To quantify the direct out-of-pocket patient co-payments and time opportunity costs (length of hospital stay) incurred by Indigenous and non-Indigenous persons diagnosed with cancer during the first year postdiagnosis. CancerCostMod was used, which is a model of cancer costs based upon a whole-of-population data linkage. The base population was a census of all persons diagnosed with cancer in Queensland, Australia between 1 July 2011 and 30 June 2012 (n = 25,553). Individual records were linked to corresponding Queensland Health Admitted Patient Data Collection, Emergency Data Information System, Medicare Benefits Schedule, and Pharmaceutical Benefits Scheme records between 1 July 2011 and 30 June 2015. Queensland data were weighted to be representative of the Australian population (approximately 123,900 Australians, 1.7% Indigenous Australians). After adjusting for age, sex, rurality, area-based deprivation, and cancer group, Indigenous Australians accrued significantly less in postdiagnosis patient co-payments at 0-6 months (61% less) and 7-12 months (63% less). Indigenous Australians also had significantly fewer postdiagnosis hospitalizations at 0-6 months (21% fewer) and 7-12 months (27% fewer). There is growing concern regarding the financial burden of cancer to the patient. The time spent away from family and their community may also have an important time opportunity cost, which may affect a person's decision to undertake or continue treatment. This is the first study in Australia to identify the financial cost of co-payments for Indigenous people with cancer, as well as the number and length of hospitalizations as drivers of time opportunity costs.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
309-315Subventions
Organisme : Menzies School of Health Research
Organisme : NHMRC
ID : #1041111
Organisme : NHMRC
ID : #1105399
Organisme : NHMRC
ID : #1058244
Organisme : Cancer Council NSW
ID : #SRP 13-01
Organisme : Cancer Council WA
Organisme : Lowitja Institute, Australia's National Institute for Aboriginal and Torres Strait Islander Health Research
Informations de copyright
© 2019 John Wiley & Sons Australia, Ltd.
Références
Australian Institute of Health and Welfare (AIHW). Australian Burden of Disease Study: impact and causes of illness and death in Australia 2011. Australian Burden of Disease Study series no 3 BOD 4. Canberra, Australia: AIHW; 2016.
Australian Institute of Health and Welfare (AIHW). Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Cancer series no. 69. Canberra, Australia: AIHW; 2012.
Gordon LG, Walker SM, Mervin MC, et al. Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. Eur J Cancer Care. 2017;26(1). https://doi.org/10.1111/ecc.12392
Gordon L, Scuffham P, Hayes S, Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psychooncology. 2007;16(12):1130-1139.
Schmitz KH, DiSipio T, Gordon LG, Hayes SC. Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care. Support Care Cancer. 2015;23(6):1807-1817.
Boyages J, Xu Y, Kalfa S, et al. Financial cost of lymphedema borne by women with breast cancer. Psychooncology. 2017;26(6):849-855.
Gordon LG, Ferguson M, Chambers SK, Dunn J. Fuel, beds, meals and meds: out-of-pocket expenses for patients with cancer in rural Queensland. Cancer Forum. 2009;33:204-210.
Newton JC, Johnson CE, Hohnen H, et al. Out-of-pocket expenses experienced by rural Western Australians diagnosed with cancer. Support Care Cancer. 2018;26(10):3543-3552.
Duckett S, Willcox S. The Australian Health Care System. 5th ed. Victoria, Australia: Oxford University Press; 2015.
Yusuf F, Leeder S. Can't escape it: the out-of-pocket cost of health care in Australia. Med J Aust. 2013;199(7):475-478.
Australian Institute of Health and Welfare (AIHW) and Cancer Australia. Cancer in Aboriginal and Torres Strait Islander peoples of Australia: an overview. Cancer series no. 78. Canberra, Australia: AIHW; 2013.
Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol. 2008;9(6):585-595.
Valery PC, Coory M, Stirling J, Green AC. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet. 2006;367(9525):1842-1848.
Supramaniam R, Gibberd A, Dillon A, Goldsbury DE, O'Connell DL. Increasing rates of surgical treatment and preventing comorbidities may increase breast cancer survival for Aboriginal women. BMC Cancer. 2014;14:163.
Hall SE, Bulsara CE, Bulsara MK, et al. Treatment patterns for cancer in Western Australia: does being Indigenous make a difference? Med J Aust. 2004;181(4):191-194.
Moore SP, Green AC, Bray F, et al. Survival disparities in Australia: an analysis of patterns of care and comorbidities among Indigenous and non-Indigenous cancer patients. BMC Cancer. 2014;14:517.
Australian Bureau of Statistics (ABS). Australian social trends, 2014. Canberra, Australia: ABS; 2014. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4102.0main+features72014
Australian Institute of Health and Welfare (AIHW). The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples 2015. Cat no. IHW 147. Canberra, Australia: AIHW; 2015.
Callander EJ, Corscadden L, Levesque JF. Out-of-pocket healthcare expenditure and chronic disease? Do Australians forgo care because of the cost? Aust J Prim Health. 2017;23(1):15-22.
Paul CL, Boyes A, Searles A, Carey M, Turon H. The impact of loss of income and medicine costs on the financial burden for cancer patients in Australia. J Community Support. 2016;14(7):307-313.
All Wales Medicines Strategy Group and US National Library of Medicine. A glossary of health economics terms: BMJ Best Practice; 2019. https://bestpractice.bmj.com/info/toolkit/ebm-toolbox/a-glossary-of-health-economics-terms/
Cummins R, Gentle I, Hull C, Community: Aboriginal and Torres Strait Islander perspectives. In: Taylor J, ed. Working with Communities. Melbourne, Australia: Oxford University Press; 2015, pp. 68-82.
Palmer S, Raftery J. Economics notes: opportunity cost. Br Med J. 1999;318(7197):1551-1552.
Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC. Out-of-pocket medical expenses for Queenslanders with a major cancer. Med J Aust. 2018;208(11):497.
Callander E, Topp SM, Larkins S, Sabesan S, Bates N. Quantifying Queensland patients with cancer health service usage and costs: study protocol. BMJ Open. 2017;7(1):e014030.
Bates N, Callander E, Lindsay D, Watt K. CancerCostMod: a model of the healthcare expenditure, patient resource use, and patient co-payment costs for Australian cancer patients. Health Econ Rev. 2018;8(1):28.
Pharmaceutical Benefits Division Department of Health. Australian statistics on medicines 2015. Canberra, Australia: Australian Government; 2016.
Australian Government Department of Health. The closing the gap: PBS co-payment measure. Canberra, Australia: Commonwealth of Australia; 2018. http://www.pbs.gov.au/info/publication/factsheets/closing-the-gap-pbs-co-payment-measure
Bell P. GREGWT and TABLE macros: users guide. Canberra, Australia: Australian Bureau of Statistics (ABS); 2000.
Reserve Bank of Australia. Inflation calculator. Sydney, Australia: Reserve Bank of Australia; 2017. http://www.rba.gov.au/calculator/
Callander E, Bates N, Lindsay D, et al. Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for Indigenous and non-Indigenous people with cancer in Australia. Int J Equity Health. 2019;18(1):32.
Paul CL, Fradgley EA, Roach D, Baird H. Impact of financial costs of cancer on patients: the Australian experience. Cancer Forum. 2017;2:4.
Garvey G, Beesley VL, Janda M, et al. Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancer. Cancer. 2015;121(17):3018-3026.
Australian Bureau of Statistics. Census of population and housing: characteristics of Aboriginal and Torres Strait Islander Australians, 2011. ABS Cat. no. 2076.0. Canberra, Australia: ABS; 2011.
Currow D, Aranda S. Financial toxicity in clinical care today: a “menu without prices”. Med J Aust. 2016;204(11):397.
Callander E, Larkins S, Corscadden L. Variations in out-of-pocket costs for primary care services across Australia: a regional analysis. Aust J Prim Health. 2017;23(4):379-385.
Taylor J, Edwards J, Champion S, et al. Towards a conceptual understanding of Aboriginal and Torres Strait Islander community and community functioning. Community Dev J. 2011;47(1):94-110.
Taylor J. Working with Communities. Melbourne, Australia: Oxford University Press; 2015.